Clinical Trial Update: DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL) [Phase 1]

View source ↗

Summary

Phase 1 trial update for DS-3201b in acute myeloid leukemia and acute lymphocytic leukemia has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• DS-3201b

Snippet

Sponsor: Daiichi Sankyo | Conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute | Phase 1 | Status: TERMINATED | Results posted: 2024-01-30